SCHEMBL7705875

SCHEMBL7705875

COc1csc(-c2nc3cc(-c4ccc(NC(C)=O)cc4)cc(N)n3n2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.42
JAK1 P23458 1/20 0.41
ALK Q9UM73 1/20 0.39
FYN P06241 2/20 0.38
KDM4E B2RXH2 4/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 2/20 0.38
PKM P14618 2/20 0.38
HPGD P15428 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
MAPT P10636 4/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CG P48736 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7709149 0.90 FYN (0.46) FYNMAPTPOLBTDP1
SCHEMBL7711838 0.86 SMN1; SMN2 (0.50) TP53JAK1KDM4ENPC1RAB9A
SCHEMBL7711818 0.83 ALDH1A1 (0.42) TP53KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL7708546 0.83 NPC1 (0.42) TP53KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL7705877 0.83 SMN1; SMN2 (0.41) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7708772 0.77 SMN1; SMN2 (0.38) FYNKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL7485272 0.75 ADORA2A (0.57) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7708412 0.75 ADORA2A (0.54) TP53KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL7433615 0.74 KDM4E (0.39) KDM4ENPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7711746 0.73 KDM4E (0.41) TP53KDM4ENPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed